Kidney cancer, ESMO 2016

被引：5
作者：
Kapoor, Anil [1 ]
机构：
[1] McMaster Univ, Surg Urol, Hamilton, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2016年 / 10卷 / 11-12期
关键词：
RENAL-CELL CARCINOMA; CABOZANTINIB; EVEROLIMUS;
D O I：
10.5489/cuaj.4282
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S227 / S230
页数：4
相关论文
共 11 条
  • [1] Atkins MB, ESMO 2016
  • [2] Cella D, ESMO 2016
  • [3] Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
    Choueiri, T. K.
    Escudier, B.
    Powles, T.
    Mainwaring, P. N.
    Rini, B. I.
    Donskov, F.
    Hammers, H.
    Hutson, T. E.
    Lee, J-L
    Peltola, K.
    Roth, B. J.
    Bjarnason, G. A.
    Geczi, L.
    Keam, B.
    Maroto, P.
    Heng, D. Y. C.
    Schmidinger, M.
    Kantoff, P. W.
    Borgman-Hagey, A.
    Hessel, C.
    Scheffold, C.
    Schwab, G. M.
    Tannir, N. M.
    Motzer, R. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) : 1814 - 1823
  • [4] Choueiri TK, 2016, ESMO 2016
  • [5] Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
    Choueiri, Toni K.
    Escudier, Bernard
    Powles, Thomas
    Tannir, Nizar M.
    Mainwaring, Paul N.
    Rini, Brian I.
    Hammers, Hans J.
    Donskov, Frede
    Roth, Bruce J.
    Peltola, Katriina
    Lee, Jae Lyun
    Heng, Daniel Y. C.
    Schmidinger, Manuela
    Agarwal, Neeraj
    Sternberg, Cora N.
    McDermott, David F.
    Aftab, Dana T.
    Hessel, Colin
    Old, Christian Scheff
    Schwab, Gisela
    Hutson, Thomas E.
    Pal, Sumanta
    Motzer, Robert J.
    [J]. LANCET ONCOLOGY, 2016, 17 (07) : 917 - 927
  • [6] Gyergyay F, ESMO 2016
  • [7] Lalani A, ESMO 2016
  • [8] Larkin J, ESMO 2016
  • [9] Powles T, ESMO 2016
  • [10] Ravaud A, 2016, ESMO 2016
12